Alpha substituted carboxylic acid as PPAR modulators
Alpha substituted carboxylic acids of formula (I): wherein R' and R2 are as defined in the specification and R3 is A) formula (II); B) formula (III); C) formula (IV); and D) formula (V); wherein Y, Art, Are, AP, R4, R5, R6, R7, R6, R9, R9a, R10, R", R12, R17, ring A, and p are as defined i...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BAILEY SIMON,HUMPHRIES PAUL STUART,SKALITZKY DONALD JAMES,SU WEI-GUO,ZEHNDER LUKE RAYMOND |
description | Alpha substituted carboxylic acids of formula (I): wherein R' and R2 are as defined in the specification and R3 is A) formula (II); B) formula (III); C) formula (IV); and D) formula (V); wherein Y, Art, Are, AP, R4, R5, R6, R7, R6, R9, R9a, R10, R", R12, R17, ring A, and p are as defined in the specification; pharmaceutical compositions containing effective amounts of said compounds or their salts are useful for treating PPAR, specifically PPAR alpha/y related disorders, such as diabetes, dyslipidemia, obesity and inflammatory disorders. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN1805943A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN1805943A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN1805943A3</originalsourceid><addsrcrecordid>eNrjZDBxzCnISFQoLk0qLsksKS1JTVFITixKyq-ozMlMVkhMzkxRSCxWCAhwDFLIzU8pzUksyS8q5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c5-hhYGppYmxo7GhFUAAHRAK8s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Alpha substituted carboxylic acid as PPAR modulators</title><source>esp@cenet</source><creator>BAILEY SIMON,HUMPHRIES PAUL STUART,SKALITZKY DONALD JAMES,SU WEI-GUO,ZEHNDER LUKE RAYMOND</creator><creatorcontrib>BAILEY SIMON,HUMPHRIES PAUL STUART,SKALITZKY DONALD JAMES,SU WEI-GUO,ZEHNDER LUKE RAYMOND</creatorcontrib><description>Alpha substituted carboxylic acids of formula (I): wherein R' and R2 are as defined in the specification and R3 is A) formula (II); B) formula (III); C) formula (IV); and D) formula (V); wherein Y, Art, Are, AP, R4, R5, R6, R7, R6, R9, R9a, R10, R", R12, R17, ring A, and p are as defined in the specification; pharmaceutical compositions containing effective amounts of said compounds or their salts are useful for treating PPAR, specifically PPAR alpha/y related disorders, such as diabetes, dyslipidemia, obesity and inflammatory disorders.</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060719&DB=EPODOC&CC=CN&NR=1805943A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060719&DB=EPODOC&CC=CN&NR=1805943A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BAILEY SIMON,HUMPHRIES PAUL STUART,SKALITZKY DONALD JAMES,SU WEI-GUO,ZEHNDER LUKE RAYMOND</creatorcontrib><title>Alpha substituted carboxylic acid as PPAR modulators</title><description>Alpha substituted carboxylic acids of formula (I): wherein R' and R2 are as defined in the specification and R3 is A) formula (II); B) formula (III); C) formula (IV); and D) formula (V); wherein Y, Art, Are, AP, R4, R5, R6, R7, R6, R9, R9a, R10, R", R12, R17, ring A, and p are as defined in the specification; pharmaceutical compositions containing effective amounts of said compounds or their salts are useful for treating PPAR, specifically PPAR alpha/y related disorders, such as diabetes, dyslipidemia, obesity and inflammatory disorders.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBxzCnISFQoLk0qLsksKS1JTVFITixKyq-ozMlMVkhMzkxRSCxWCAhwDFLIzU8pzUksyS8q5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c5-hhYGppYmxo7GhFUAAHRAK8s</recordid><startdate>20060719</startdate><enddate>20060719</enddate><creator>BAILEY SIMON,HUMPHRIES PAUL STUART,SKALITZKY DONALD JAMES,SU WEI-GUO,ZEHNDER LUKE RAYMOND</creator><scope>EVB</scope></search><sort><creationdate>20060719</creationdate><title>Alpha substituted carboxylic acid as PPAR modulators</title><author>BAILEY SIMON,HUMPHRIES PAUL STUART,SKALITZKY DONALD JAMES,SU WEI-GUO,ZEHNDER LUKE RAYMOND</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN1805943A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>BAILEY SIMON,HUMPHRIES PAUL STUART,SKALITZKY DONALD JAMES,SU WEI-GUO,ZEHNDER LUKE RAYMOND</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BAILEY SIMON,HUMPHRIES PAUL STUART,SKALITZKY DONALD JAMES,SU WEI-GUO,ZEHNDER LUKE RAYMOND</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Alpha substituted carboxylic acid as PPAR modulators</title><date>2006-07-19</date><risdate>2006</risdate><abstract>Alpha substituted carboxylic acids of formula (I): wherein R' and R2 are as defined in the specification and R3 is A) formula (II); B) formula (III); C) formula (IV); and D) formula (V); wherein Y, Art, Are, AP, R4, R5, R6, R7, R6, R9, R9a, R10, R", R12, R17, ring A, and p are as defined in the specification; pharmaceutical compositions containing effective amounts of said compounds or their salts are useful for treating PPAR, specifically PPAR alpha/y related disorders, such as diabetes, dyslipidemia, obesity and inflammatory disorders.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_CN1805943A |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
title | Alpha substituted carboxylic acid as PPAR modulators |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T20%3A48%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BAILEY%20SIMON,HUMPHRIES%20PAUL%20STUART,SKALITZKY%20DONALD%20JAMES,SU%20WEI-GUO,ZEHNDER%20LUKE%20RAYMOND&rft.date=2006-07-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN1805943A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |